
Gaudium IVF Shares Make Strong Debut on NSE and BSE, List at ₹83 with 5.06% Premium
Gaudium IVF & Women Health IPO Listing
Listing Date: February 27, 2024
Gaudium IVF & Women Health Limited, a leader in assisted reproductive technologies, will debut in the Indian stock market today following the completion of its initial public offering (IPO). The public issue, valued at ₹165 crores, was open for subscription from February 20 to February 24.
IPO Details
- Issue Price: ₹79 per equity share of the face value of ₹5
- GMP (Grey Market Premium): ₹0, indicating no premium or discount in the grey market
- Allotment Status: Finalized on February 25
- Listing Exchanges: BSE and NSE
Company Overview
Founded by Khanna, Gaudium IVF has positioned itself as a leader in assisted reproductive technologies within India. The organization operates using a hub-and-spoke model, consisting of seven hubs and 28 spokes in various states.
Financial Performance
Read also: SMR Jewels IPO Successfully Lists with Institutional Support
- FY24: Operational revenue of ₹47.89 crore and a profit after tax (PAT) of ₹10.31 crore
- FY25: Operational revenue of ₹70.72 crore and a PAT of ₹19.13 crore
IPO Allocation
- QIB (Qualified Institutional Buyers): Not more than 50% of the shares
- NII (Non Institutional Investors): Not less than 15% of the shares
- Retail Investors: Not less than 35% of the offer
Investor Takeaway
Gaudium IVF shares have made a strong debut on the Indian stock market with a 5.06% premium.
More in IPO

SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

SMR Jewels IPO Successfully Lists with Institutional Support

Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO
